Cent Eur J Public Health 2021, 29(2):90-95 | DOI: 10.21101/cejph.a6623

Breast and cervical cancer screening attendance among Czech women

Anna Altová1, Ivana Kulhánová1, 2, Lukáš Brůha3, Michala Lustigová2, 4
1 Department of Demography and Geodemography, Faculty of Science, Charles University, Prague, Czech Republic
2 Department of Social Geography and Regional Development, Faculty of Science, Charles University, Prague, Czech Republic
3 Department of Applied Geoinformatics and Cartography, Faculty of Science, Charles University, Prague, Czech Republic
4 National Institute of Public Health, Prague, Czech Republic

Objectives: The aim of the study was to investigate the variation in breast and cervical cancer screening attendance among Czech women by age and in regions in 2009-2017.

Methods: The data from the health insurance company that covers around 50% of the Czech population were used to calculate age-specific attendance rates and standardized attendance rates by year and region.

Results: In 2017, the attendance of all eligible women was 52% in breast cancer screening and 46% in cervical cancer screening. There were differences in attendance among groups of women. Women aged 45-49 had attendance rates in both screenings around 60%, while 39% of women aged 75-79 attended breast cancer screening, and 23% attended cervical cancer screening. In regions, attendance ranged from 38% to 70% in breast cancer screening and from 32% to 55% in cervical cancer screening.

Conclusions: We identified the age-specific differences and regional variation in both breast and cervical cancer screening attendance among Czech women. Those with lower attendance may have a higher risk of dying from breast and cervical cancers. Mitigating this risk should be a priority of public health policies.

Keywords: cancer screening, breast cancer, cervical cancer, cancer prevention, Czechia

Received: November 12, 2020; Revised: May 5, 2021; Accepted: May 5, 2021; Published: June 30, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Altová A, Kulhánová I, Brůha L, Lustigová M. Breast and cervical cancer screening attendance among Czech women. Cent Eur J Public Health. 2021;29(2):90-95. doi: 10.21101/cejph.a6623. PubMed PMID: 34245547.
Download citation

Attachments

Download filedoi: 10.21101/cejph.b0144

b0144_supplementary_material_to_a6623.pdf
File size: 1.45 MB

References

  1. Czech Statistical Office. Number of deaths by cause, sex and age in CR, regions and districts - 2009 to 2018: regions by sex and age in 2017 [Internet]. Prague: CZSO; 2019 [cited 2020 May 14]. Available from: https://www.czso.cz/csu/czso/kraje-podle-pohlavi-a-veku-za-rok-2017-a7bdxth904. (In Czech.)
  2. Dušek L, Mužík J, Kubásek M, Koptíková J, Žaloudík J, Vyzula R. Epidemiology of malignant tumors in the Czech Republic [Internet]. Brno: Masaryk University; 2005 [cited 2020 May 14]. Available from: https://svod.cz/.
  3. Eurostat. Cause of death - standardised death rate by residence [Internet]. Luxembourg: European Comission; 2020 [cited 2020 May 14]. Available from: https://appsso.eurostat.ec.europa.eu/nui/show.do?dataset=hlth_cd_asdr2〈=en.
  4. Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, et al. Benefits and harms of breast cancer screening: a systematic review. JAMA. 2015 Oct 20;314(15):1615-34. Go to original source... Go to PubMed...
  5. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013 Jun 11;108(11):2205-40. Go to original source... Go to PubMed...
  6. Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet. 2004 Jul 17-23;364(9430):249-56. Go to original source... Go to PubMed...
  7. Landy R, Pesola F, Castañón A, Sasieni P. Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study. Br J Cancer. 2016 Oct 25;115(9):1140-6. Go to original source... Go to PubMed...
  8. Galit W, Green MS, Lital KB. Routine screening mammography in women older than 74 years: a review of the available data. Maturitas. 2007 Jun 20;57(2):109-19. Go to original source... Go to PubMed...
  9. Kamineni A, Weinmann S, Shy KK, Glass AG, Weiss NS. Efficacy of screening in preventing cervical cancer among older women. Cancer Causes Control. 2013 Sep;24(9):1653-60. Go to original source... Go to PubMed...
  10. Walter LC, Schonberg MA. Screening mammography in older women: a review. JAMA. 2014 Apr 2;311(13):1336-47. Go to original source... Go to PubMed...
  11. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, editors. European guidelines for quality assurance in breast cancer screening and diagnosis. 4th ed. Luxembourg: European Communities; 2006.
  12. Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, et al, editors. European guidelines for quality assurance in cervical cancer screening. 2nd ed. [Internet]. Luxembourg: European Communities; 2008 [cited 2020 May 13]. Available from: https://screening.iarc.fr/doc/ND7007117ENC_002.pdf.
  13. Recommended standards for providing breast cancer screening and diagnostic mammography in the Czech Republic. Věstník MZ ČR. 2010;Pt 4:4-34. (In Czech.)
  14. Ponti A, Anttila A, Ronco G, Senore C, Basu P, Segnan N, et al. Cancer screening in the European Union (2017): report on the implementation of the Council Recommendation on cancer screening. Lyon: IARC; 2017.
  15. Terms and conditions of cervical cancer screening programme in the Czech Republic. Věstník MZ ČR. 2007;Pt 7:147-51. (In Czech.)
  16. Czech Society for Oncology. Invitations to cancer screening [Internet]. CSO; 2020 [cited 2020 Sep 2]. Available from: https://www.linkos.cz/onkologicka-prevence/screening/adresne-zvani-do-programu-screeningu/. (In Czech.) Go to PubMed...
  17. Bulliard J-L, Garcia M, Blom J, Senore C, Mai V, Klabunde C. Sorting out measures and definitions of screening participation to improve comparability: the example of colorectal cancer. Eur J Cancer. 2014 Jan;50(2):434-46. Go to original source... Go to PubMed...
  18. Majek O, Danes J, Skovajsova M, Bartonkova H, Buresova L, Klimes D, et al. Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme. BMC Public Health. 2011 May 10;11:288. doi: 10.1186/1471-2458-11-288. Go to original source... Go to PubMed...
  19. Kinkorová J, Topolčan O. Overview of healthcare system in the Czech Republic. EPMA J. 2012 Feb 28;3(1):4. doi: 10.1007/s13167-012-0139-9. Go to original source... Go to PubMed...
  20. Eurostat. Local Administrative Units (LAU) [Internet]. Luxembourg: Eurostat; 2020 [cited 2020 Sep 2]. Available from: https://ec.europa.eu/eurostat/web/nuts/local-administrative-units.
  21. Revision of the European Standard Population: report of Eurostat's task force. Methodologies and working papers [Internet]. Luxembourg: European Union; 2013 [cited 2020 May 28]. Available from: https://ec.europa.eu/eurostat/documents/3859598/5926869/KS-RA-13-028-EN.PDF/e713fa79-1add-44e8-b23d-5e8fa09b3f8f.
  22. Edwards NI, Jones DA. Uptake of breast cancer screening in older women. Age Ageing. 2000;29(2):131-5. Go to original source... Go to PubMed...
  23. Institute of Health Information and Statistics of the Czech Republic. Health care of the Czech Republic: Overview of the gynecology and obstetrics field activity in 2007-2017. NHIS report, no. K/8 (08/2018) [Internet]. Prague: IHIS CR; 2018 [cited 2020 May 14]. Available from: https://www.uzis.cz/index.php?pg=record&id=8107. (In Czech.)
  24. Kučera Z, Pelikan J, Šteflová A. Health literacy in Czech population results of the comparative representative research. Cas Lek Cesk. 2016;155(5):233-41. (In Czech.) Go to PubMed...
  25. Leung J, Macleod C, McLaughlin D, Woods LM, Henderson R, Watson A, et al. Screening mammography uptake within Australia and Scotland in rural and urban populations. Prev Med Rep. 2015 Jun 24;2:559-62. Go to original source... Go to PubMed...